aeterna zentaris - Robuta Search

https://www.entrepreneur.com/business-news/should-you-buy-aeterna-zentaris-under-1/390188 Should You Buy Aeterna Zentaris Under $1? Sep 3, 2025 - Drug development company Aeterna Zentaris (AEZS), specialized in oncology and endocrine, has made significant advancements in areas of unmet medical needs. But... you buy aeterna zentaris 1 https://www.globenewswire.com/news-release/2018/01/17/1295621/0/en/Aeterna-Zentaris-Enters-into-Licensing-and-Assignment-Agreement-with-Strongbridge-for-Macrilen-macimorelin-in-the-U-S-and-Canada.html Aeterna Zentaris Enters into Licensing and Assignment CHARLESTON, S.C., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) announced today that it has, through a wholly-owned... aeterna zentaris enters licensing assignment https://www.biospace.com/aeterna-zentaris-reports-fourth-quarter-and-full-year-2013-financial-and-operating-results AEterna Zentaris Reports Fourth Quarter And Full-Year 2013 Financial And Operating Results -... aeterna zentaris fourth quarter https://www.finder.com/stock-trading/buy-aeterna-zentaris-stock How to Buy Aeterna Zentaris Stock (AEZS) Aug 6, 2021 - We explain how to buy Aeterna Zentaris Inc stock, compare the best stock trading platforms and use a detailed analysis to learn about (AEZS). how to buy aeterna zentaris stock https://www.prnewswire.com/news-releases/aeterna-zentaris-to-raise-us78-million-in-registered-direct-offering-216914101.html Aeterna Zentaris to Raise US$7.8 Million in Registered Direct Offering /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced today that it has received commitments from institutional investors... aeterna zentaris raise us 7 8 https://www.biospace.com/aeterna-zentaris-receives-10-million-from-institutional-investors AEterna Zentaris Receives $10 Million from Institutional Investors - BioSpace aeterna zentaris 10 million institutional investors receives https://www.biospace.com/aeterna-zentaris-to-announce-third-quarter-2013-financial-and-operating-results-on-november-5-2013 AEterna Zentaris to Announce Third Quarter 2013 Financial and Operating Results on November 5, 2013... https://www.biospace.com/aeterna-zentaris-to-announce-second-quarter-2015-financial-and-operating-results-on-august-13-2015 AEterna Zentaris To Announce Second Quarter 2015 Financial And Operating Results On August 13, 2015... https://www.businesswire.com/news/home/20230315005851/it Pharmanovia stipula un accordo di licenza esclusiva con Aeterna Zentaris per il primo e unico... Pharmanovia, casa farmaceutica globale che commercializza medicinali innovativi e rivitalizza, estende ed espande il ciclo di vita dei prodotti consolidati, ... https://sheffield.ac.uk/smph/news/aeterna-zentaris-announces-notice-allowance-us-patent-covering-aezs-150-potential-treatment-chronic Aeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential... Aeterna Zentaris Inc. today announced that its licensor, The University of Sheffield, has received a notice of allowance from the U.S. Patent and Trademark... https://www.businesswire.com/news/home/20230315005846/en/Pharmanovia-Enters-Into-an-Exclusive-Licensing-Agreement-With-Aeterna-Zentaris-for-the-First-and-Only-Orally-Administered-Approved-Medicine-for-the-Diagnosis-of-Growth-Hormone-Deficiency-in-Adults Pharmanovia Enters Into an Exclusive Licensing Agreement With Aeterna Zentaris for the First and... Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines,... https://www.biospace.com/aeterna-zentaris-signs-transfer-agreement-of-its-discovery-library-with-the-medical-university-of-south-carolina AEterna Zentaris Signs Transfer Agreement Of Its Discovery Library With The Medical University of...